SMFM's 39th Annual Pregnancy Meeting

Working together for the global advancement of safe and healthy pregnancies

February 11 - 16, 2019 | Caesars Palace | Las Vegas, Nevada

15. USA vs. Europe Debates (Diabetes, Hyperglycemia)

Feb. 13, 2019 8am - 2:30pm

Course Directors:
Vincenzo Berghella, MD
Mary D'Alton, MD
Gian Carlo Di Renzo, MD, PhD
Moshe Hod, MD

Course Faculty:
Aaron Caughey, MD, PhD
Donald Coustan, MD
Celeste Durnwald, MD
Lisa Hollier, MD, MPH
Anil Kapur, MD
Mark Landon, MD
David McIntyre, MD
Erika Werner, MD
Yariv Yogev, MD

Hear American and European leaders debate the best way to treat diabetes and hyperglycemia. Evaluate the best screening tests for gestational diabetes and learn the best treatment options. Learn how to provide more therapeutic options for patients and how to better screen for it postpartum.

This course is approved for 5 AMA PRA Category 1 Credits. 

LEARNING OBJECTIVES
 
1.         Evaluate the best screening tests for gestational diabetes. 
2.         Better manage gestational diabetes. 
3.         Assess the best therapeutic options for diabetes in pregnancy. 
4.         Better manage maternal diabetes in the postpartum period. 
5.         Assess how to best screen for diabetes postpartum.  

COURSE SCHEDULE 

Session Time Session Title Session Speaker
8:00-8:10am Introduction and Poll Berghella, D'Alton, Hod, Di Renzo
8:10-8:20am The Beginning
From O’Sullivan and Mahan To Carpenter and Coustan: How Did it All Start?        
Coustan (USA)
8:20-8:30am The Evidence
Connecting Glucose Values to Adverse Pregnancy Outcome – The HAPO Study 
Hod (FIGO, Israel)
8:30-8:50am The Guidelines
Hyperglycemia in Pregnancy (HIP) – The Guidelines 
Hod (FIGO, Israel)
  FIGO vs ACOG where do we differ? Caughey (USA)
8:50-9:00am Discussion Faculty
  Debating Diagnosis of GDM                            Coordinator: Hod (FIGO, Israel)
  No Dispute, Just the Facts  
9:00-9:20am Universal – FIGO and ACOG Werner (USA)
  Selective – NICE (UK) McIntyre (FIGO, Australia)
9:20-9:40am One Step – FIGO McIntyre (FIGO, Australia)
  Two Step Testing – ACOG Berghella (USA)
  The Issue of “Two Abnormal Values”  
9:40-10:00am One Value is Enough – FIGO
Coustan (USA)
  No, Two Values are Needed – ACOG Durnwald (USA)
10:00-10:30am Break  
  The Fasting Glucose of 5.1 mM/92 mg/dL  
10:30-10:50am Yes – FIGO McIntyre (FIGO, Australia)
  No – ACOG Landon (USA)
10:50-11:00am Discussion Faculty
  Discussing Management of GDM                           Coordinator: Berghella (USA)
11:00-11:15am All You Have to Know – Oral Hypoglycemic Agents (OHA)
Glyburide or Metformin?
Yogev (Israel)
11:15-11:30am Is it Possible to Predict and Prevent Hyperglycemia in Pregnancy? Di Renzo (FIGO, Italy)
11:30-11:45am Barriers and Pragmatic Solutions to Improve Postpartum Care Kapur (FIGO, India)
11:45am-12:00pm Discussion Faculty
12:00-1:00pm Lunch
  Postpartum – Life Course Approach
No Dispute – Providing Evidence  
 
1:00-1:30pm Variations Between Regions / Ethnicities
  HAPO Follow Up Study Data Coustan (USA)
  GDM and T2DM and CV Risk Hollier (ACOG, USA)
  No Dispute – Providing Evidence   
1:30-2:00pm Health Economics Caughey (ACOG, USA)
Kapur (FIGO, India)
2:00-2:10pm Discussion Faculty
  Panel Discussion and Poll
HIP – Towards a Consensus
Coordinator: Hod (FIGO, Israel)
2:10-2:30pm What Can We Agree Upon and What Needs to be Provided to Close the Gaps?

1. Universal Testing and Early Testing (with Repeat Test at 24-28 Weeks if Needed)
2. Single Step Testing
3. Point of Care Testing and Diagnosis   
4. Single Abnormal Reading Being Considered Diagnostic
5. Fasting Glucose of 5.1 mM /92 mg/dL
D’Alton (ACOG/SMFM, USA) 

Price: $650.00